Comparison Between Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol to Estimate Cardiovascular Risk Using a Multivariate Model

被引:7
|
作者
Palazon-Bru, Antonio [1 ]
Antonio Carbayo-Herencia, Julio [1 ,2 ]
Simarro-Rueda, Marta [3 ]
Miguel Artigao-Rodenas, Luis [4 ]
Antonio Divison-Garrote, Juan [5 ]
Molina-Escribano, Francisca [6 ]
Ponce-Garcia, Isabel [7 ]
Francisco Gil-Guillen, Vicente [8 ]
Ponce-Garcia, I
Simarro-Rueda, M.
Carbayo-Herencia, J. A.
Palazon-Bru, Antonio [1 ]
Divison-Garrote, J. A.
Artigao-Rodenas, L. M.
Gil-Guillen, V
Sanchis-Domenech, C.
Masso-Orozco, J.
Torres-Moreno, P.
Navarro-Sanchez, L.
Gonzalez-Lozano, B.
Martinez-Ramirez, M.
Martinez-Navarro, E.
Rodriguez-Panos, B.
Garcia-Gosalvez, F.
Molina-Escribano, F.
Martinez-Lopez, R.
Lopez-Abril, J.
Caldevilla-Bernardo, D.
Lopez-de-Coca-y-Fernandez-Valencia, E.
Argandona-Palacios, E.
Monedero-Laorden, J.
Campayo-Serrano, A.
机构
[1] Miguel Hernandez Univ, Dept Clin Med, Carretera Valencia Alicante S-N, Alacant 03550, Spain
[2] Quironsalud Hosp, Lipids Unit, Albacete, Spain
[3] Zone IV Primary Care Hlth Ctr, Hlth Syst Castilla Mancha, Albacete, Spain
[4] Zone III Primary Care Hlth Ctr, Hlth Syst Castilla Mancha, Albacete, Spain
[5] Catholic Univ Murcia, Cathedra Primary Hlth Care, Murcia, Spain
[6] Casas Ibanez Primary Care Hlth Ctr, Hlth Syst Castilla Mancha, Albacete, Spain
[7] Alcadozo Primary Care Hlth Ctr, Hlth Syst Castilla Mancha, Albacete, Spain
[8] Miguel Hernandez Univ, Dept Clin Med, Alacant, Spain
关键词
cardiovascular diseases/epidemiology; cholesterol; HDL; LDL/blood; cholesterol/blood; models; statistical; CORONARY-HEART-DISEASE; NON-HDL CHOLESTEROL; APOLIPOPROTEIN-B; LDL-CHOLESTEROL; ISCHEMIC-STROKE; LIPID MEASURES; INDIVIDUALS; PREDICTION; EVENTS; METAANALYSIS;
D O I
10.1097/JCN.0000000000000534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although studies exist comparing low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (HDL-C) in the development of cardiovascular disease (CVD), most have limitations in the mathematical models used to evaluate their prognostic power adjusted for the other risk factors (cardiovascular risk). Objective: The aim of this study was to compare LDL-C and non-HDL-C in patients with CVD to determine whether both parameters predict CVD similarly. Methods: A cohort of 1322 subjects drawn from the general population of a Spanish region was followed between 1992 and 2006. The outcome was time to CVD. Secondary variables were gender, age, hypertension, diabetes, personal history of CVD, current smoker, body mass index, LDL-C, and non-HDL-C. Two CVD prediction models were constructed with the secondary variables, with only the lipid parameter varying (non-HDL-C or LDL-C). In the construction of the models, the following were considered: multiple imputation, events per variable of 10 or more, and continuous predictors as powers. The validation was conducted by bootstrapping obtaining the distribution of the C statistic (discrimination) and the probabilities observed by smooth curves. These results were compared in both models using graphical and analytical testing. Results: There were a total of 137 CVD events. The models showed no differences in the distributions of the C statistic (discrimination, P = .536) or in the calibration plot. Conclusions: In our population, LDL-C and non-HDL-C were equivalent at predicting CVD. More studies using this methodology are needed to confirm these results.
引用
收藏
页码:E17 / E23
页数:7
相关论文
共 50 条
  • [21] Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein, Apolipoprotein, or Low-Density Lipoprotein Particle What Should Clinicians Measure?
    Davidson, Michael H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (25) : 2616 - 2617
  • [22] Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B: relationships among the different measurements
    Franzini, C
    Valente, C
    Luraschi, P
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2004, 64 (08): : 703 - 707
  • [23] Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study
    Okamura, Tomonori
    Kokubo, Yoshihiro
    Watanabe, Makoto
    Higashiyama, Aya
    Miyamoto, Yoshihiro
    Yoshimasa, Yasunao
    Okayama, Akira
    ATHEROSCLEROSIS, 2009, 203 (02) : 587 - 592
  • [24] Addressing cardiovascular risk beyond low-density lipoprotein cholesterol: The high-density lipoprotein cholesterol story
    Meagher E.A.
    Current Cardiology Reports, 2004, 6 (6) : 457 - 463
  • [25] Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study
    Wu, Jianwei
    Chen, Shengyun
    Liu, Liping
    Gao, Xiang
    Zhou, Yong
    Wang, Chunxue
    Zhang, Qian
    Wang, Anxin
    Hussain, Mohammed
    Sun, Baoying
    Wu, Shouling
    Zhao, Xingquan
    NEUROLOGICAL RESEARCH, 2013, 35 (05) : 505 - 511
  • [26] Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
    Willeit, Peter
    Yeang, Calvin
    Moriarty, Patrick M.
    Tschiderer, Lena
    Varvel, Stephen A.
    McConnell, Joseph P.
    Tsimikas, Sotirios
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (23):
  • [27] Cardiovascular Risk Beyond Low-Density Lipoprotein Cholesterol
    Mayr, Manuel
    Gerszten, Robert
    Kiechl, Stefan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (06) : 633 - 635
  • [28] Variability in Low-Density Lipoprotein Cholesterol and Cardiovascular Risk
    Baber, Usman
    Halperin, Jonathan L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (15) : 1549 - 1551
  • [29] Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease
    You, Jiayin
    Wang, Zhenhao
    Lu, Guoping
    Chen, Zhenyue
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [30] Assessment of reaching goal in patients with combined hyperlipidemia: Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B
    Stein, EA
    Sniderman, A
    Laskarzewski, P
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (9A): : 36K - 43K